# Post Approval Study of the remedē System

> **NCT03425188** · — · COMPLETED · sponsor: **Respicardia, Inc.** · enrollment: 53 (actual)

## Conditions studied

- Central Sleep Apnea

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03425188
- **Lead sponsor:** Respicardia, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-28
- **Primary completion:** 2020-08-04
- **Final completion:** 2020-08-04
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2021-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03425188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03425188, "Post Approval Study of the remedē System". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03425188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*